Choosing between these two depends on your medical history, tolerance threshold, and how your genetics influence peptide sensitivity
In addition to the statements FDA made regarding enforcement in connection with litigation (see FDAs updates on October 22, 2024, below), to avoid unnecessary disruption to patient treatment, the agency does not intend to take action against compounders for violations of the FD&C Act arising from conditions that depend on tirzepatide injection products inclusion on FDAs drug shortage list: For a state-licensed pharmacy under section 503A of the FD&C Act compounding, distributing or dispensing tirzepatide injections within 60 calendar days from todays announcement, until February 18, 2025
Dose adjustments are normal
discuss with your healthcare provider Pediatric patients: Not approved for patients under 12 years of age Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous serious allergic reaction to Semaglutide Always discuss your complete medical history and list of medications with your healthcare provider before starting Semaglutide treatment
Optimizing results while on GLP-1 therapy Peptides alone won't maximize outcomes
(So I know I can help you) I know exactly what to tell my patients when they plateau or get stuck
.png)
